Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for P14719

Entry ID Method Resolution Chain Position Source
5VI4 X-ray 279 A B/E 26-326 PDB
AF-P14719-F1 Predicted AlphaFoldDB

33 variants for P14719

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1133019593 5 Q>R No EVA
rs1133847496 16 T>A No EVA
rs1132357396 19 M>V No EVA
rs3388467130 35 N>D No EVA
rs260927391 44 Q>K No EVA
rs3388465063 69 N>Y No EVA
rs3388465058 131 S>L No EVA
rs260943543 192 A>S No EVA
rs51401641 192 A>V strain: C3H/He [UniProt] No EVA
rs3388465104 203 T>N No EVA
rs3388465503 252 A>V No EVA
rs3388465577 253 D>G No EVA
rs3388466604 261 T>A No EVA
rs3388466809 266 F>C No EVA
rs3388467076 266 F>L No EVA
rs1134458377 300 K>Q No EVA
rs3388466520 306 Y>C No EVA
rs3388466826 324 R>S No EVA
rs3388466198 338 V>I No EVA
rs3388467359 355 L>F No EVA
rs259636271 368 D>G No EVA
rs1133996513 376 R>W No EVA
rs214759597 400 H>R No EVA
rs47001137 413 V>I No EVA
rs3389887408 433 Q>P No EVA
rs52008393 445 N>S No EVA
rs252948089 460 S>N No EVA
rs3388465576 463 F>V No EVA
rs236413291 492 E>K No EVA
rs3388467540 493 A>T No EVA
rs3388466926 516 K>E No EVA
rs3388466399 532 F>L No EVA
rs261337760 549 T>M No EVA

No associated diseases with P14719

2 regional properties for P14719

Type Name Position InterPro Accession
domain STAG 225 - 343 IPR013721
domain Stromalin conservative domain 367 - 457 IPR020839

Functions

Description
EC Number 3.2.2.6 Hydrolyzing N-glycosyl compounds
Subcellular Localization
  • Cell membrane; Single-pass type I membrane protein
  • ;
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
cell surface The external part of the cell wall and/or plasma membrane.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
external side of plasma membrane The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
extracellular space That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
focal adhesion A cell-substrate junction that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. In insects focal adhesion has also been referred to as hemi-adherens junction (HAJ).
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

5 GO annotations of molecular function

Name Definition
interleukin-1 receptor activity Combining with interleukin-1 to initiate a change in cell activity. Interleukin-1 is produced mainly by activated macrophages and is involved in the inflammatory response.
interleukin-33 binding Binding to interleukin-33.
interleukin-33 receptor activity Combining with interleukin-33 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
NAD(P)+ nucleosidase activity Catalysis of the reaction: NAD(P)+ + H2O = ADP-ribose(P) + nicotinamide.
NAD+ nucleotidase, cyclic ADP-ribose generating Catalysis of the reaction: NAD+ + H2O = nicotinamide + ADP-ribose that proceeds in a stepwise fashion by ADP-ribosyl cyclase activity followed by cyclic ADP-ribose hydrolase activity.

7 GO annotations of biological process

Name Definition
negative regulation of cell population proliferation Any process that stops, prevents or reduces the rate or extent of cell proliferation.
negative regulation of interferon-gamma production Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
negative regulation of T-helper 1 type immune response Any process that stops, prevents, or reduces the frequency, rate, or extent of a T-helper 1 type immune response.
positive regulation of chemokine production Any process that activates or increases the frequency, rate, or extent of chemokine production.
positive regulation of inflammatory response Any process that activates or increases the frequency, rate or extent of the inflammatory response.
positive regulation of interleukin-5 production Any process that activates or increases the frequency, rate, or extent of interleukin-5 production.
positive regulation of macrophage activation Any process that stimulates, induces or increases the rate of macrophage activation.

6 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P14778 IL1R1 Interleukin-1 receptor type 1 Homo sapiens (Human) PR
P27930 IL1R2 Interleukin-1 receptor type 2 Homo sapiens (Human) PR
Q9NPH3 IL1RAP Interleukin-1 receptor accessory protein Homo sapiens (Human) PR
Q61730 Il1rap Interleukin-1 receptor accessory protein Mus musculus (Mouse) PR
Q9Z2B1 Il18rap Interleukin-18 receptor accessory protein Mus musculus (Mouse) PR
P13504 Il1r1 Interleukin-1 receptor type 1 Mus musculus (Mouse) PR
10 20 30 40 50 60
MIDRQRMGLW ALAILTLPMY LTVTEGSKSS WGLENEALIV RCPQRGRSTY PVEWYYSDTN
70 80 90 100 110 120
ESIPTQKRNR IFVSRDRLKF LPARVEDSGI YACVIRSPNL NKTGYLNVTI HKKPPSCNIP
130 140 150 160 170 180
DYLMYSTVRG SDKNFKITCP TIDLYNWTAP VQWFKNCKAL QEPRFRAHRS YLFIDNVTHD
190 200 210 220 230 240
DEGDYTCQFT HAENGTNYIV TATRSFTVEE KGFSMFPVIT NPPYNHTMEV EIGKPASIAC
250 260 270 280 290 300
SACFGKGSHF LADVLWQINK TVVGNFGEAR IQEEEGRNES SSNDMDCLTS VLRITGVTEK
310 320 330 340 350 360
DLSLEYDCLA LNLHGMIRHT IRLRRKQPID HRSIYYIVAG CSLLLMFINV LVIVLKVFWI
370 380 390 400 410 420
EVALFWRDIV TPYKTRNDGK LYDAYIIYPR VFRGSAAGTH SVEYFVHHTL PDVLENKCGY
430 440 450 460 470 480
KLCIYGRDLL PGQDAATVVE SSIQNSRRQV FVLAPHMMHS KEFAYEQEIA LHSALIQNNS
490 500 510 520 530 540
KVILIEMEPL GEASRLQVGD LQDSLQHLVK IQGTIKWRED HVADKQSLSS KFWKHVRYQM
550 560
PVPERASKTA SVAAPLSGKA CLDLKHF